Consumers are increasingly interested in incorporating functional or adaptogenic mushrooms into their diets due to their potential health benefits, such as boosting immunity, reducing inflammation, and promoting overall...more
In a previous article, we explored one potential current opportunity for entrepreneurs interested in psychedelics and mycelium—producing non-psychoactive mushroom supplements. But are there any current commercial...more
5/31/2022
/ Clinical Trials ,
Food and Drug Administration (FDA) ,
Life Sciences ,
Pharmaceutical Industry ,
Popular ,
Proposed Legislation ,
Regulatory Standards ,
Religious Beliefs ,
Religious Exemption ,
Religious Freedom Restoration Act (RFRA) ,
Research and Development
Aside from a small number of companies the FDA has permitted to pursue the development of psilocybin therapies (e.g., Compass), the majority of psychedelic mushroom sales in the U.S. currently violate both state and federal...more
12/3/2021
/ Adverse Events ,
Advertising ,
Biologics ,
Controlled Substances Act ,
Dietary Supplements ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Food and Drug Administration (FDA) ,
GRAS ,
Labeling ,
Life Sciences ,
Marijuana ,
Popular ,
Reporting Requirements
What is a REIT?
“REIT” stands for Real Estate Investment Trust. Typically, a REIT is a corporation that has elected to be taxed as a REIT (which provides several tax advantages, including the ability to deduct dividends from...more
4/26/2021
/ Cannabis-Related Businesses (CRBs) ,
Capital Raising ,
Consolidated Appropriations Act (CAA) ,
Controlled Substances Act ,
Decriminalization of Marijuana ,
Internal Revenue Code (IRC) ,
Investors ,
Marijuana ,
Marijuana Related Businesses ,
Medical Marijuana ,
Popular ,
Private Equity ,
Real Estate Investments ,
Real Estate Market ,
REIT ,
Shareholders ,
Tenants ,
Vetting